What is the fundamental immunological defect in autoimmune rheumatic diseases?
Master all 26 flashcards
Mechanisms of immune dysregulation, autoantibody production, and tissue damage in rheumatologic conditions.
This deck provides a comprehensive understanding of the immune mechanisms underlying rheumatic diseases, enabling clinicians to interpret laboratory findings, recognize disease patterns, and tailor management strategies based on pathophysiological insights. Mastery of these concepts enhances diagnostic accuracy and supports personalized patient care.
ℹ️ Educational Use Only: This flashcard deck is created by usersof our platform for their educational and study purposes. The content is not intended as medical advice, diagnosis, or treatment guidance. Always consult qualified healthcare professionals for medical decisions and verify information with authoritative medical sources.
Showing 20 of 26 cardsSample view
| # | Front | Back | Hint |
|---|---|---|---|
| 1 | What is the fundamental immunological defect in autoimmune rheumatic diseases? | The fundamental defect is a loss of immune tolerance, leading to an inappropriate immune response against self-antigens due to dysregulated immune regulation, including defective T-cell and B-cell tolerance mechanisms. | Think of immune tolerance as the immune system's 'self-check'; failure leads to autoimmunity. |
| 2 | How do autoantibodies contribute to tissue damage in autoimmune rheumatic diseases? | Autoantibodies target self-antigens, forming immune complexes that deposit in tissues, activate complement pathways, and initiate inflammation, leading to tissue injury and clinical manifestations. | Remember: autoantibodies + antigens = immune complexes causing damage. |
| 3 | What role does molecular mimicry play in the development of autoimmune rheumatic diseases? | Molecular mimicry occurs when structural similarities between microbial antigens and self-antigens induce cross-reactive immune responses, triggering autoimmunity after infection. | Think of the immune system confusing microbial proteins with self-proteins. |
| 4 | Name two key immune cells involved in the pathogenesis of autoimmune rheumatic diseases. | T lymphocytes (particularly Th1 and Th17 subsets) and B lymphocytes play central roles; T cells help activate B cells, which produce pathogenic autoantibodies. | Remember: T cells are the 'generals,' B cells are the 'arms' producing antibodies. |
| 5 | Describe the process of epitope spreading in autoimmune disease progression. | Epitope spreading refers to the diversification of the immune response from initially targeted self-antigens to other epitopes within the same or different self-proteins, worsening tissue damage over time. | Think of it as the immune system 'spreading its attack' to multiple self-components. |
| 6 | What is the significance of HLA gene associations in autoimmune rheumatic diseases? | Certain HLA alleles (e.g., HLA-DR4 in RA, HLA-DR3 in SLE) confer genetic susceptibility by influencing antigen presentation and immune response regulation, increasing disease risk. | HLA genes act as the 'self' identifiers that can predispose to autoimmunity. |
| 7 | How does complement activation contribute to tissue injury in autoimmune rheumatic diseases? | Autoantibody-antigen immune complexes activate the classical complement pathway, leading to inflammation, recruitment of immune cells, and tissue destruction. | Complement acts like an 'amplifier' of immune response, causing collateral tissue damage. |
| 8 | What is the role of apoptosis in the development of autoimmunity? | Defective clearance of apoptotic debris exposes intracellular antigens to the immune system, promoting autoantibody production and breaking self-tolerance. | Think of apoptotic debris as 'self-antigen leaks' that trigger immune responses. |
| 9 | Explain how cytokines contribute to the pathophysiology of autoimmune rheumatic diseases. | Pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-17) promote immune cell recruitment, activation, and perpetuation of inflammation, leading to tissue damage. | Cytokines are like 'immune messengers' that amplify inflammation. |
| 10 | What is the significance of neoantigen formation in autoimmunity? | Neoantigens are modified self-proteins generated by processes like oxidation or citrullination, which are recognized as foreign, triggering autoimmune responses. | Neoantigens are 'self-objects' that the immune system mistakenly perceives as non-self. |
| 11 | How does environmental exposure influence the pathophysiology of autoimmune rheumatic diseases? | Environmental factors such as infections, smoking, and silica exposure can induce post-translational modifications of self-antigens or activate innate immunity, contributing to loss of tolerance. | Environmental triggers act as 'ignition sources' for genetic susceptibility. |
| 12 | Describe the role of regulatory T cells (Tregs) in preventing autoimmunity. | Tregs suppress autoreactive immune responses, maintaining self-tolerance; deficiency or dysfunction of Tregs predisposes to autoimmune disease. | Think of Tregs as the 'immune system's peacekeepers.' |
| 13 | What is the significance of B cell hyperactivity in autoimmune rheumatic diseases? | B cell hyperactivity leads to increased autoantibody production, antigen presentation, and cytokine secretion, all of which exacerbate tissue damage. | B cells are the 'autoantibody factories' in autoimmunity. |
| 14 | Explain how genetic susceptibility and environmental factors interact in the pathogenesis of autoimmune rheumatic diseases. | Genetic predisposition provides a susceptible background, while environmental triggers initiate or exacerbate immune dysregulation, culminating in disease development. | Think of genetics as the 'blueprint' and environment as the 'construction site.' |
| 15 | What is the role of autoantibodies in the clinical manifestations of systemic lupus erythematosus (SLE)? | Autoantibodies form immune complexes that deposit in tissues, causing inflammation and damage in organs such as the kidneys, skin, and joints, leading to diverse clinical features. | Autoantibodies = 'molecular missiles' targeting self-tissues. |
| 16 | How does defective clearance of immune complexes contribute to ongoing inflammation in autoimmune diseases? | Impaired removal of immune complexes prolongs their presence in tissues, perpetuating complement activation and inflammation. | Think of it as 'trash accumulation' fueling ongoing tissue injury. |
| 17 | What is the importance of autoantibody specificity in diagnosing rheumatic diseases? | Specific autoantibodies (e.g., anti-dsDNA in SLE, anti-CCP in RA) serve as diagnostic markers and can correlate with disease activity and prognosis. | Autoantibody 'signatures' help identify specific diseases. |
| 18 | Describe the mechanism by which anti-citrullinated protein antibodies (ACPAs) contribute to rheumatoid arthritis. | ACPAs target citrullinated proteins in joints, forming immune complexes that activate complement and inflammatory cells, leading to synovial inflammation and joint destruction. | Citrullination is a post-translational modification that triggers autoimmunity. |
| 19 | What is the role of innate immunity in the initial stages of autoimmune rheumatic diseases? | Innate immune responses, via pattern recognition receptors (e.g., Toll-like receptors), recognize self-nucleic acids or modified proteins, initiating inflammation and activating adaptive immunity. | Innate immunity acts as the immune system's 'first responder.' |
| 20 | How does epigenetic modification influence autoimmunity? | Epigenetic changes, such as DNA methylation and histone modifications, can alter gene expression in immune cells, promoting autoreactivity and persistent inflammation. | Epigenetics is like 'software updates' changing immune cell behavior. |
Note: This preview shows only the first 20 cards. The complete deck contains 26 total cards. Start studying to access all flashcards.
Master all 26 flashcards
Explore other decks you might find helpful